ArticlePloS one2020

Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer.

Melinda Lillesand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.